verapamil has been researched along with fibrinogen in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, L; Retzinger, GS | 1 |
| Gardner, DV; Green, D; Neely, SM; Reynolds, N; Ts'ao, CH | 1 |
| Aungst, BJ; Saitoh, H | 1 |
| Björkander, I; Forslund, L; Håkan Wallén, N; Held, C; Hjemdahl, P; Rehnqvist, N; Wiman, B | 1 |
1 trial(s) available for verapamil and fibrinogen
| Article | Year |
|---|---|
Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
Topics: Adrenergic beta-Agonists; Aged; Angina Pectoris; beta-Thromboglobulin; Calcium Channel Blockers; Cardiovascular Diseases; Double-Blind Method; Female; Fibrinogen; Hemostasis; Humans; Inflammation; Leukocyte Count; Male; Metoprolol; Middle Aged; Multivariate Analysis; Orosomucoid; Prognosis; Verapamil | 2000 |
3 other study(ies) available for verapamil and fibrinogen
| Article | Year |
|---|---|
Discontinuous alterations of platelet structure and function by bound, ionizable verapamil.
Topics: Absorption; Adenosine Diphosphate; Blood Platelets; Cell Membrane; Fibrinogen; Humans; Hydrogen-Ion Concentration; Platelet Aggregation; Platelet Aggregation Inhibitors; Verapamil | 1992 |
Mechanism and characteristics of platelet activation by haematin.
Topics: Adenosine Triphosphate; Apyrase; Blood Platelet Disorders; Blood Platelets; Cations, Divalent; Child; Epoprostenol; Female; Fibrinogen; Heme; Hemin; Heparin; Humans; Microscopy, Electron; Platelet Aggregation; Prostaglandin D2; Prostaglandins D; Prostaglandins, Synthetic; Thromboxanes; Verapamil | 1984 |
Intestinal absorption barriers and transport mechanisms, including secretory transport, for a cyclic peptide, fibrinogen antagonist.
Topics: Animals; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Dose-Response Relationship, Drug; Drug Interactions; Fibrinogen; Intestinal Absorption; Intestinal Mucosa; Male; Mesylates; Peptides, Cyclic; Platelet Aggregation Inhibitors; Protons; Rats; Rats, Sprague-Dawley; Verapamil | 1996 |